Open Access. Powered by Scholars. Published by Universities.®
Pharmacy and Pharmaceutical Sciences
Institute for Pharmaceutical Outcomes and Policy Faculty Publications
- Keyword
-
- Abuse (1)
- Adolescent (1)
- Adult (1)
- Aged (1)
- Atypical antipsychotics (1)
-
- Cross-Sectional Studies (1)
- Drug Industry (1)
- Drugs, Generic (1)
- Female (1)
- Generic drugs (1)
- Humans (1)
- Insurance, Pharmaceutical Services (1)
- Logistic Models (1)
- Male (1)
- Medicaid (1)
- Medicare (1)
- Middle Aged (1)
- Misuse (1)
- Pharmaceutical marketing (1)
- Physician prescribing (1)
- Prescription Drugs (1)
- Quetiapine (1)
- Sample medications (1)
- Surveys and Questionnaires (1)
- United States (1)
- Young Adult (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Quetiapine Misuse And Abuse: Is It An Atypical Paradigm Of Drug Seeking Behavior?, Sean Hyungwoo Kim, Gayoung Lee, Eric Kim, Hyejin Jung, Jongwha Chang
Quetiapine Misuse And Abuse: Is It An Atypical Paradigm Of Drug Seeking Behavior?, Sean Hyungwoo Kim, Gayoung Lee, Eric Kim, Hyejin Jung, Jongwha Chang
Institute for Pharmaceutical Outcomes and Policy Faculty Publications
Recent case reports in medical literatures suggest that more and more second-generation atypical antipsychotics (AAs) have been prescribed for off-label use; quetiapine (Brand name: Seroquel®) showed increase in its trend for off-label use. Little is known about the reasons behind this trend, although historical sedative and hypnotic prescription patterns suggest that despite relatively superior safety profiles of quetiapine (especially for movement disorders), it may be used for treating substance abuse disorder. In addition, recent studies have shown a strong potential for misuse and abuse (MUA) of quetiapine beyond Food and Drug Administration-approved indications. This includes drug-seeking behaviors, such …
Utilization Of Free Medication Samples In The United States In A Nationally Representative Sample: 2009-2013, Joshua D. Brown, Pratik A. Doshi, Jeffery C. Talbert
Utilization Of Free Medication Samples In The United States In A Nationally Representative Sample: 2009-2013, Joshua D. Brown, Pratik A. Doshi, Jeffery C. Talbert
Institute for Pharmaceutical Outcomes and Policy Faculty Publications
Background—Manufacturers provide free sample medications as a means to increase use of branded medications. Sample use varies year-to-year as branded product patents expire and new products come to market.
Objective—This study sought to describe the use of sample medications during 2009–2013 and assess individual characteristics associated with sample use.
Methods—Data from the 2009–2013 U.S. Medical Expenditure Panel Survey (MEPS) were used. MEPS asks participants whether they received each medication they are taking as a sample. The top 10 medications and medication classes used each year by volume were identified as well as the proportion of people who …